These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26446314)

  • 1. NASH, from diagnosis to treatment: Where do we stand?
    Harrison SA
    Hepatology; 2015 Dec; 62(6):1652-5. PubMed ID: 26446314
    [No Abstract]   [Full Text] [Related]  

  • 2. Management and diagnosis of fatty liver disease.
    Schneier AT; Citti CC; Dieterich DT
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):671-83. PubMed ID: 25716275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management.
    Salomone F; Zelber-Sagi S; Galvano F; Fabbrini E
    Biomed Res Int; 2015; 2015():153276. PubMed ID: 26290862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy].
    Ströhle A; Stein J
    Med Monatsschr Pharm; 2015 May; 38(5):166-78; quiz 179-80. PubMed ID: 26364406
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-alcoholic fatty liver diseases].
    Roeb E; Steffen HM; Bojunga J
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1846. PubMed ID: 26625237
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 8. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver: yet another silent killer.
    Javed M
    J Ayub Med Coll Abbottabad; 2014; 26(1):1-2. PubMed ID: 25358204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis].
    Bernal-Reyes R
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():84-6. PubMed ID: 22939493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and treatment of non-alcoholic fatty liver disease].
    Su W; Cao H; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):705-7. PubMed ID: 25647847
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of NASH: What Helps Beyond Weight Loss?
    Banini BA; Sanyal AJ
    Am J Gastroenterol; 2017 Jun; 112(6):821-824. PubMed ID: 28397875
    [No Abstract]   [Full Text] [Related]  

  • 13. Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Raziel A; Sakran N; Szold A; Goitein D
    Isr Med Assoc J; 2015 Apr; 17(4):234-8. PubMed ID: 26040050
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE.
    Golovanova EV; Lazebnik LB
    Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-alcoholic fatty liver disease. Role of primary care physicians].
    Caballeria J; Caballeria L
    Med Clin (Barc); 2015 Aug; 145(3):112-4. PubMed ID: 26004277
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.
    Eng K; Lopez R; Liccardo D; Nobili V; Alkhouri N
    Dig Liver Dis; 2014 Nov; 46(11):1008-13. PubMed ID: 25106814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013].
    Shen F; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):178-80. PubMed ID: 24919224
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of fatty liver disease with the metabolic syndrome.
    Machado MV; Cortez-Pinto H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.